Coronavirus vaccine replace: Oxford vaccine can nonetheless be prepared by year-end, says AstraZeneca CEO | The Occasions of India

Whereas the British drugmaker didn’t touch upon the tentative timeline when the trial would resume, AstraZeneca Plc Chief Govt Officer, Pascal Soriot stated that the Oxford coronavirus might nonetheless be made accessible by the top of 2020.

“I nonetheless assume we’re on observe for having a set of knowledge that we’d submit earlier than the top of the yr for regulatory approval,” Pascal stated at a media occasion.

He added that relying on “how briskly the regulators transfer, they might nonetheless have a vaccine by the top of this yr, early subsequent yr.”